Track topics on Twitter Track topics that are important to you
Latest global life science, pharmaceutical and healthcare news syndicated from over 50 publishers.
Injectable testosterone esters and transdermal testosterone gels have generally been assumed to be equally safe and effective forms of testosterone-replacement therapy for male hypogonadism. Now, findings from a recent study suggest that transdermal ...
* Obamacare to drive revenue growth as global tech spending falls
SALMON, Idaho (Reuters) - It is not easy being a vampire, and even harder to come out of the coffin to a physician or therapist for fear they will misinterpret the habit of ingesting the blood of willing donors or succumb to stereotyping, a study fin...
Lilly is seeking the FDA's blessing to market necitumumab in combination with gemcitabine and cisplatin for use in first-line treatment of patients with locally advanced or metastatic squamous NSCLC.
LAS VEGAS, July 07, 2015 (GLOBE NEWSWIRE) -- Allegiant Travel Company (NASDAQ:ALGT) today reported preliminary passenger traffic results for June 2015. Scheduled Service
NEW YORK, July 07, 2015 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Celladon Corporation (“Celladon” or the “Company”) (NASDAQ:CLDN) and certain of its officers. The class action, filed in United States District Court, Southern District of California, is on behalf of a class consisting of all persons or entities who purchased Cell...
Specialty trials services and tech provider BioClinica has acquired the patient recruitment and retention firm, MediciGroup. Financial terms of the deal were not disclosed.
With a House floor vote looming this week, legislators will decide on a revised bill that has decreased the amount of funding that will go to the NIH from the original bill, and removed a section that would have required NIH grant recipients to share scientific data.
CHARLOTTE, NC -- (Marketwired) -- 07/07/15 -- Severe weather can cause major damage to a home, sometimes with little warning. With the start of hurricane season this month, residents in Florida, t...
Allergan will have four migraine therapies in its portfolio after licensing two oral CGRP antagonists for treatment and prevention of the debilitating headaches from Merck & Co, joining a field crowded with injectable CGRP-targeting biologics.
Specifically the drug – a combination of sacubitril, a neprilysin inhibitor, and valsartan, an angiotensin II receptor blocker – is indicated to reduce the risk of cardiovascular death and hospitalization for heart failure in patients wit...
(Reuters) - Health insurer Humana Inc and buyer Aetna Inc set fees to be paid in the event of a failure of the largest deal in the health insurance industry.
Depomed is willing to bet it on its recent launch of pain drug Nucynta, rather than take Horizon Pharma at its current offer of $29.25 per share. The specialty pharma thinks there is more value in going it alone, but they might be passing up a solid....
(Reuters Health) - Use of indoor tanning is on the decline, according to a new study from the Centers for Disease Control and Prevention (CDC) and the National Cancer Institute.
Of the 330 investors that allocated funding to digital health companies in the first quarter, just under one third or 108 were new to the sector.
A research letter about healthcare data breaches, published in the Journal of the American Medical Association in April, contained numerous errors, the authors and the publication admitted, though none apparently affected the study's conclusions.
(Reuters) - Novartis AG on Tuesday won U.S. approval for its keenly awaited new heart failure drug Entresto earlier than expected, boosting hopes for a medicine tipped by analysts to reap billions of dollars in annual sales.
* Consensus forecasts point to sales of $4.4 bln in 2020 (Adds byline, details on price, side effects)
* Health sources say test results inconclusive (Adds two new cases confirmed)
Novartis' heart failure drug gets speedy US approval